Bath & Body Works, Inc. (NYSE:BBWI) Stock Rated "Hold" by Wall Street Brokerages

Key Points

• Analyst consensus is “Hold”: Of 20 analysts, 15 rate Bath & Body Works neutral, four rate it a buy and one recommends selling. The average 12-month price target is $22.13.
• Quarterly earnings beat expectations: The company reported adjusted EPS of $0.62 versus estimates of $0.24 and revenue of $1.51 billion, although revenue declined 2.3% year over year.
• Shares and dividend: BBWI recently traded at $20.96, with a 3.8% dividend yield based on its $0.20 quarterly payout. Institutional investors own approximately 95.14% of the stock.

Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) have received a consensus rating of "Hold" from the twenty analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, fifteen have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $22.13.

Several research firms have recently issued reports on BBWI. Wells Fargo & Company lowered their target price on shares of Bath & Body Works from $26.00 to $24.00 and set an "overweight" rating for the company in a report on Thursday, August 27th. The Goldman Sachs Group lowered Bath & Body Works from a "neutral" rating to a "sell" rating and reduced their price objective for the company from $23.00 to $19.00 in a research report on Wednesday, July 8th. JPMorgan Chase & Co. lifted their price objective on Bath & Body Works from $22.00 to $24.00 and gave the company a "neutral" rating in a research note on Tuesday, August 18th. Weiss Ratings reissued a "hold (c-)" rating on shares of Bath & Body Works in a report on Tuesday, October 6th. Finally, Argus reissued a "hold" rating on shares of Bath & Body Works in a report on Wednesday, September 16th.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds have recently bought and sold shares of BBWI. Elevation Wealth Partners LLC grew its position in Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company's stock valued at $41,000 after purchasing an additional 1,742 shares during the last quarter. Parallel Advisors LLC lifted its stake in shares of Bath & Body Works by 35.5% in the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company's stock worth $48,000 after buying an additional 673 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Bath & Body Works in the second quarter worth approximately $66,000. Global Retirement Partners LLC bought a new position in shares of Bath & Body Works in the second quarter worth approximately $71,000. Finally, Root Financial Partners LLC grew its holdings in shares of Bath & Body Works by 4,485.7% during the first quarter. Root Financial Partners LLC now owns 3,210 shares of the company's stock valued at $60,000 after buying an additional 3,140 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 2.9%

BBWI opened at $20.96 on Friday. The company has a market cap of $4.23 billion, a price-to-earnings ratio of 5.46, a price-to-earnings-growth ratio of 1.05 and a beta of 1.40. The stock has a fifty day simple moving average of $18.31 and a two-hundred day simple moving average of $19.12. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $27.40.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.51 billion for the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the previous year, the business posted $0.30 EPS. The company's quarterly revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, analysts predict that Bath & Body Works will post 2.73 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 4th. Stockholders of record on Friday, August 21st were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.8%. The ex-dividend date of this dividend was Friday, August 21st. Bath & Body Works's payout ratio is currently 20.83%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its merchandise includes body lotions, shower gels, fragrances, soaps, hand sanitizers, candles, air fresheners and other fragrance-focused items sold under the Bath & Body Works brand.

The company operates through a network of retail stores and digital commerce channels, serving customers primarily in the United States and Canada. Its products are also available internationally through select partners, including franchise, wholesale and other distribution arrangements.

Bath & Body Works traces its origins to 1990 and was formerly part of L Brands, Inc The company became an independent publicly traded business in 2021 after separating from L Brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.